TrialSignal
Clinical trial intelligence report
The Association Between Anti-osteoporosis Medications and Lowered All Cause Mortality After Osteoporotic Fractures
Source-linked diligence brief with registry provenance, taxonomy normalization and premium analytical context.
Generated
Jun 20, 2026
NCT ID
NCT05366621
Status
COMPLETED
Phase
Completed
Sponsor
National Cheng-Kung University Hospital
Executive brief
Investment-Ready Snapshot
This observational study aimed to assess the relationship between anti-osteoporosis medications and all-cause mortality in older adults following osteoporotic fractures. Conducted by National Cheng-Kung University Hospital, it involved a cohort of 216,155 participants and spanned a 12-year observation period.
Source & freshness
Provenance
https://clinicaltrials.gov/study/NCT05366621
Indication
Osteoporosis
Modality
monoclonal antibody
Target
Osteoporosis and Mortality
Intervention
Anti-osteoporosis medications
Source record
Protocol Description
Detailed source ingestion pending.
Source record
Outcome Measures
Detailed source ingestion pending.
Source record
Eligibility
Detailed source ingestion pending.
AI analysis
Known Results And Readout Context
Detailed source ingestion pending.
IP intelligence
Patent And IP Landscape
Detailed source ingestion pending.
Source record
Contacts
Detailed source ingestion pending.